PA
EDSA icon

Perceptive Advisors’s Edesa Biotech EDSA Stock Holding History

Perceptive Advisors’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.95M Buy
+563,239
New +$1.69M 0.06% 83

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Perceptive Advisors's EDSA Position: Q1 2026 in Review

Perceptive Advisors opened a new position in Edesa Biotech (EDSA) in Q1 2026: 563,239 shares worth $2.95M. The stake represents 0.06% of the portfolio and ranks #83 among its holdings.

28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.

  • Perceptive Advisors held 563,239 shares of Edesa Biotech worth $2.95M as of Q1 2026.
  • Edesa Biotech was a new Perceptive Advisors position in Q1 2026.
  • Edesa Biotech made up 0.06% of Perceptive Advisors's portfolio in Q1 2026, its #83 holding.
  • 28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.